Publications by authors named "Matthias Perleth"

Claim this Profile
H
Hyperbaric oxygen therapy for acute idiopathic sudden sensorineural hearing loss; a systematic review with meta-analysis.
Annemarie Newth, Matthias Perleth, Susannah Sherlock, Lorena Romero, Michael H Bennett

Diving Hyperb Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Making the case for a more sustainable health care system - The role of technology assessment].
Matthias Perleth, Barbara Buchberger, Peter Kolominsky-Rabas

Z Evid Fortbild Qual Gesundhwes· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of living evidence formats for coverage decisions in the German health care system.
Susann Conrad, Jelka Hartwig, Lydia Jones, Robert C Lorenz, Matthias Perleth

Z Evid Fortbild Qual Gesundhwes· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Report on the workshop "Environmental Impact: A new dimension in health technology assessment? A workshop focussing on medical devices", EbM Congress in Potsdam on March 23, 2023].
Matthias Perleth, Anne Spranger, Katharina Wabnitz, Dimitra Panteli, Peter Kolominsky-Rabas

Z Evid Fortbild Qual Gesundhwes· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-based health policy in Germany: lack of communication and coordination between academia and health authorities?
Charlotte Mareike Kugler, Matthias Perleth, Tim Mathes, Kaethe Goossen, Dawid Pieper

Syst Rev· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum zu "Wie belastbar sind Studien der aktuell dauerhaft aufgenommenen digitalen Gesundheitsanwendungen (DiGA)? Methodische Qualität der Studien zum Nachweis positiver Versorgungseffekte von DiGA" [Z. Evid. Fortbild. Gesund. Wesen 2022;175:1-16].
Peter L Kolominsky-Rabas, Martin Tauscher, Roman Gerlach, Matthias Perleth, Nikolas Dietzel

Z Evid Fortbild Qual Gesundhwes· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[How robust are studies of currently permanently included digital health applications (DiGA)? Methodological quality of studies demonstrating positive health care effects of DiGA].
Peter L Kolominsky-Rabas, Martin Tauscher, Roman Gerlach, Matthias Perleth, Nikolas Dietzel

Z Evid Fortbild Qual Gesundhwes· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disruptive technologies in health care disenchanted: a systematic review of concepts and examples.
Matthias Perleth, Rossella Di Bidino, Li-Ying Huang, Lydia Jones, Michelle Mujoomdar

Int J Technol Assess Health Care· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Evaluation of Orphan Drugs by the German Joint Federal Committee-An Eight-Year Review.
Sandra Schulz, Anna Marie Passon, Matthias Perleth, Michael Kulig, Nina Paschke

Dtsch Arztebl Int· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A new definition for Health Technology Assessment, HTA, translation with commentary].
Matthias Perleth, Claudia Wild

Z Evid Fortbild Qual Gesundhwes· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Around the Tables - Contextual Factors in Healthcare Coverage Decisions Across Western Europe.
Tineke Kleinhout-Vliek, Antoinette de Bont, Meindert Boysen, Matthias Perleth, Romke van der Veen

Int J Health Policy Manag· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing a new taxonomic model for the assessment of medical devices: Is it plausible and applicable? Insights from HTA reports and interviews with HTA institutions in Europe.
Sabine Fuchs, Britta Olberg, Matthias Perleth, Reinhard Busse, Dimitra Panteli

Health Policy· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Studies in Rare Diseases: A Descriptive Analysis of Completed Orphan Drug Benefit Assessments at the Federal Joint Committee].
Sandra Schulz, Anna Passon, Michael Kulig, Matthias Perleth, Katja Matthias

Gesundheitswesen· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health].
Johannes Morche, Susann Conrad, Anna Passon, Matthias Perleth, Gerald Gartlehner

Z Evid Fortbild Qual Gesundhwes· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scientific Evidence in Health Technology Assessment Reports: An In-Depth Analysis of European Assessments on High-Risk Medical Devices.
Britta Olberg, Sabine Fuchs, Dimitra Panteli, Matthias Perleth, Reinhard Busse

Value Health· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-based decision-making for diagnostic and therapeutic methods: the changing landscape of assessment approaches in Germany.
Britta Olberg, Sabine Fuchs, Katja Matthias, Alexandra Nolting, Matthias Perleth

Health Res Policy Syst· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HTA of medical devices: Challenges and ideas for the future from a European perspective.
Sabine Fuchs, Britta Olberg, Dimitra Panteli, Matthias Perleth, Reinhard Busse

Health Policy· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QUALITY OF SAMPLE SIZE ESTIMATION IN TRIALS OF MEDICAL DEVICES: HIGH-RISK DEVICES FOR NEUROLOGICAL CONDITIONS AS EXAMPLE.
Britta Olberg, Matthias Perleth, Katja Felgentraeger, Sandra Schulz, Reinhard Busse

Int J Technol Assess Health Care· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community.
Bernhard Ultsch, Oliver Damm, Philippe Beutels, Joke Bilcke, Bernd Brüggenjürgen, Matthias Perleth

Pharmacoeconomics· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[GRADE guidelines: 13. Preparing Summary of Findings tables and evidence profiles - continuous outcomes].
Lisa K Schell, Joerg J Meerpohl, Gerald Gartlehner, Gero Langer, Matthias Perleth

Z Evid Fortbild Qual Gesundhwes· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Is the medical exam according to §25 SGB V still currently valid?].
Norbert Donner-Banzhoff, Matthias Perleth

Z Evid Fortbild Qual Gesundhwes· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The periodic health examination: from law to the directive of the German Federal Joint Committee (G-BA)].
Matthias Perleth, Katja Matthias

Z Evid Fortbild Qual Gesundhwes· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAXONOMY OF MEDICAL DEVICES IN THE LOGIC OF HEALTH TECHNOLOGY ASSESSMENT.
Cornelia Henschke, Dimitra Panteli, Matthias Perleth, Reinhard Busse

Int J Technol Assess Health Care· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[GRADE guidelines: 12. Developing Summary of Findings tables - dichotomous outcomes].
Gero Langer, Joerg J Meerpohl, Matthias Perleth, Gerald Gartlehner, Holger Schünemann

Z Evid Fortbild Qual Gesundhwes· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The new regulation to investigate potentially beneficial diagnostic and therapeutic methods in Germany: up to international standard?
Britta Olberg, Matthias Perleth, Reinhard Busse

Health Policy· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis